Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients

Patients with chronic obstructive pulmonary disease (COPD) are prone to developing arterial hypertension, and many patients are treated with the calcium channel blocker amlodipine. However, it remains unclear whether using this drug potentially affects the risk of acute severe exacerbations (AECOPD)...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ema Rastoder, Pradeesh Sivapalan, Josefin Eklöf, Imane Achir Alispahic, Alexander Svorre Jordan, Christian B. Laursen, Jørgen Vestbo, Christine Jenkins, Rune Nielsen, Per Bakke, Gustavo Fernandez-Romero, Daniel Modin, Niklas Johansen, Filip Soeskov Davidovski, Tor Biering-Sørensen, Jørn Carlsen, Jens Ulrik Stæhr Jensen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2023-07-01
Saila:	Biomedicines
Gaiak:	COPD calcium channel blockers thiazide exacerbations amlodipine bendroflumethiazide
Sarrera elektronikoa:	https://www.mdpi.com/2227-9059/11/7/1974
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!